Navigation Links
ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update
Date:8/11/2008

Conference call scheduled for August 12, 2008 at 1:30 p.m. (Pacific Time);

simultaneous webcast at http://www.adventrx.com

SAN DIEGO, Aug. 11 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease, today reported financial results for the three-month and six-month periods ended June 30, 2008.

"During the second quarter of this year, we continued to make advances with respect to the on-going development and our commercialization plans for both ANX-530 (vinorelbine emulsion) as well as ANX-514 (docetaxel emulsion)," stated Evan M. Levine, Chief Executive Officer and President of ADVENTRX. "We continued to make progress with regard to the preparation of our NDA submission for ANX-530 as well as conducting our registrational bioequivalence clinical study of ANX-514. Furthermore, we made a considerable investment of capital this quarter in order to initiate large scale manufacturing to prepare for the commercial launch of both ANX-530 and ANX-514. This is a significant endeavor that will help enable us to successfully launch these product candidates if they are approved. As well, we announced response rate data from 2 separate studies of CoFactor(R), our third oncology product candidate. We continue to evaluate CoFactor and expect to provide further updates with respect to the program as we gather additional data."

Three-Month Period Ended June 30, 2008 Operating Results

ADVENTRX's net loss was $6.4 million, or $0.07 per share, for the three-month period ended J
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results
2. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
3. ADVENTRX Pharmaceuticals to Present at the 2007 RBC Capital Markets Healthcare Conference
4. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIO-Europe Partnering Conference
5. ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference
6. Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
7. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
8. Alseres Pharmaceuticals to Host 2008 Second Quarter Conference Call
9. Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
10. Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization
11. NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... September 17, 2014 Why are Asian Americans at ... Americans, and prone to develop the disease at lower ... in the transition from traditional high-fiber, low-fat Asian diets ... for those of Asian heritage, says George King, M.D., ... Diabetes Center and the senior author of the study. ...
(Date:9/17/2014)... GA (PRWEB) September 17, 2014 Leading ... to announce the launch of its new vegan and ... is extremely effective and provided the results skincare testers ... to create a gentle yet active mask that provided ... Lake Louise.” , This Sugar Cane Fruit Mask combines ...
(Date:9/17/2014)... The Delta Dental Community Care Foundation announced today ... Health Foundation: America’s ToothFairy (NCOHF) to support oral health ... Zone Program® in California. , The Orange County NCOHF ... local constituent groups and stakeholders in a comprehensive approach ... its devastating effects on local families. The support of ...
(Date:9/17/2014)... 17, 2014 (HealthDay News) -- Managing diabetes, quitting smoking, ... weight can reduce the risk for dementia -- even ... The World Alzheimer Report 2014, commissioned by Alzheimer,s Disease ... dementia by 50 percent. The study noted that obesity ... diabetes as well as high blood pressure. ...
(Date:9/17/2014)... WASHINGTON -- The U.S. health care system is not ... the end of life and those of their families, ... a new report from the Institute of Medicine. ... approach to end-of-life care that integrates traditional medical care ... sustainable. The committee called for more "advance care ...
Breaking Medicine News(10 mins):Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 2Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 3Health News:EcoBeauty Brand Lotus Moon Unveils New Gluten-Free Sugar Cane Fruit Mask 2Health News:Delta Dental Community Care Foundation Donation to America's ToothFairy Helps Deliver Critical Services 2Health News:Healthy Lifestyle Changes Linked to Reduced Risk for Dementia 2Health News:Healthy Lifestyle Changes Linked to Reduced Risk for Dementia 3Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 2Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 3Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 4Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 5
... in Complex Rehab IndustryWILKES-BARRE, Pa., March 11 James ... years of experience, has joined Alliance Seating & ... accredited complex rehab companies. Conwell is an Assistive ... Supplier (CRTS) in Wilkes-Barre, Pa., for ASM ( www.alliance-seating.com ...
... Prevention, Treatment and Care Services for People around ... March 11 Late yesterday the ... Omnibus Appropriations bill for fiscal year 2009. ... last week, contains an appropriation of $900 million ...
... The U.S. Agency for International Development (USAID) ... launched a new program to reduce HIV vulnerability of ... The three-year, $5.1 million project is funded by the ... administered by USAID . A recent release study ...
... of cancer cells and their frequent divisions have their ... cells. Their metabolism runs at full speed and requires ... of iron in the cell lead to the production ... these, the cell inactivates free iron by binding it ...
... Amex: FHC ) today announced that it will ... of the FC2 Female Condom(R) on Thursday, March ... Company announced its receipt of FDA approval for the ... Shareholders and other interested parties may participate in the conference ...
... ROSEMONT, Ill., March 11 /PRNewswire-USNewswire/ -- Orthopaedic surgeon ... of Councilors (BOC) of the American Academy of ... the Venetian Sands Expo Center in Las Vegas. He ... "As Secretary, I will be one of the voices for ...
Cached Medicine News:Health News:Veteran Rehab Specialist, James Conwell, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania 2Health News:Congress Approves FY2009 Omnibus Appropriations Bill with $900 Million for The Global Fund 2Health News:USAID and IOM Announce HIV Prevention and Care for Farm Workers 2Health News:The Female Health Company Schedules Conference Call to Discuss FDA Approval of FC2 Female Condom(R) for March 12, 2009 2Health News:The Female Health Company Schedules Conference Call to Discuss FDA Approval of FC2 Female Condom(R) for March 12, 2009 3Health News:David Teuscher, MD, Elected Secretary of Academy Board of Councilors 2
(Date:9/17/2014)... Minn. , Sept. 17, 2014  Rebiotix Inc. announced ... the company,s lead product candidate, RBX2660 (microbiota suspension) will be ... IDWeek 2014 conference in Philadelphia from ... be presented during the poster session on Thursday, October 9, ... C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD ...
(Date:9/17/2014)... , September 17, 2014 ... 17536, has shown positive data in a Phase 2a ... neuropathy , Glenmark Pharmaceuticals today ... Ankyrin 1 (TRPA1) antagonist, GRC 17536 has shown positive ... multi-centre, proof of concept study conducted on 138 patients ...
(Date:9/17/2014)... 2014  Members of the physician IT team ... announced today that the enterprise is working with ... sharing capabilities and provide immediate cluster fail over ... addition, the Dicom Systems enterprise imaging solutions will ... to more effectively deliver the right images to ...
Breaking Medicine Technology:PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 2PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 4Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 2Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 3
... CARY, N.C., March 15, 2011 Saffron ... firm providing Natural Intelligence(1) solutions for business and ... leaders to its corporate Advisory Board . ... business-technology acumen, rich global business experience, and broad ...
... XTIO2 INC . (XTI) presented ... XTI ANTI-GERM / ANTI-VOC / ANTI-ALLERGY SYSTEM , consisting ...  Nano-Facemask . It is the world,s most effective preventive ... air and contact surfaces. The unique nanocoating protects people ...
Cached Medicine Technology:Saffron Technology Adds Seasoned Business Executives to Advisory Board 2Saffron Technology Adds Seasoned Business Executives to Advisory Board 3OSCAR® Nominees Receive (XTIO2 INC.) XTI 360™ Nano Coating Anti-Germ System 2OSCAR® Nominees Receive (XTIO2 INC.) XTI 360™ Nano Coating Anti-Germ System 3
5.5 pointed curved blade. Octagonal handle....
2 mm wide curved tip. Round handle....
3 mm disposable Lance blade. Can fit in to the N0521 Storz handle....
Consist of 6 disposable bevel blades (N0522) and chuck handle (0521). Malleable shafts. Designated most popular model or size....
Medicine Products: